Press release
Investigation announced for Investors in shares of Stem, Inc. (NYSE: STEM) over potential Wrongdoing

An investigation on behalf of investors in Stem, Inc. (NYSE: STEM) shares over potential wrongdoing at Stem, Inc. was announced.
Investors who purchased shares of Stem, Inc. (NYSE: STEM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Stem, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
San Francisco, CA based Stem, Inc. operates as a digitally connected and intelligent energy storage network provider in the United States and internationally. Stem, Inc. reported that its annual Total Revenue rose from $36.3 million in 2020 to $127.37 million in 2021, and that its Net Loss declined from $156.12 million in 2020 to $101.21 million in 2021.
On January 11, 2023, Blue Orca Capital issued a short report alleging multiple claims. The report claims that it has uncovered "undisclosed to investors, STEM is financing its flagship customer to purchase energy storage systems from STEM. Rather than a "big win" and proof that STEM could compete for big utility scale projects, we think STEM won its supposed flagship deal by surreptitiously paying for it."
Shares of Stem, Inc. (NYSE: STEM) declined from $9.40 per share on January 10, 2023, to $8.35 per share on January 11, 2023. Since then shares of Stem, Inc. (NYSE: STEM) rose to $11.00 per share on January 18, 2023.
Those who purchased shares of Stem, Inc. (NYSE: STEM) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
                     Copy
                  
                 Please set a link in the press area of your homepage to this press release on openPR.  openPR disclaims liability for any content contained in this release. 
    You can edit or delete your press release Investigation announced for Investors in shares of Stem, Inc. (NYSE: STEM) over potential Wrongdoing here
News-ID: 2934862 • Views: …
More Releases from Shareholders Foundation
                                            
                                                    Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE:  …                                                
                                            
                                        
                                            An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…  
                                        
                                    
                                            
                                                    Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …                                                
                                            
                                        
                                            An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. 
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…  
                                        
                                    
                                            
                                                    Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …                                                
                                            
                                        
                                            An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…  
                                        
                                    
                                            
                                                    Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025                                                
                                            
                                        
                                            A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. 
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…  
                                        
                                    More Releases for Stem
                                                    Animal Stem Cell Therapy Market Worth Observing Growth| Cell Therapy Sciences, M …                                                
                                            
                                        
                                            Advance Market Analytics published a new research publication on "Animal Stem Cell Therapy Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Stem Cell Therapy market was mainly driven by the increasing R&D spending across the world. Some of…  
                                        
                                    
                                                    Introducing My STEM Resume: The Ultimate Solution for STEM Professionals                                                
                                            
                                        
                                            As STEM industries continue to grow, so does the demand for qualified professionals. Yet, many STEM students and professionals face challenges in effectively showcasing their skills and experience to prospective employers. Recognizing this need, Brendon, a seasoned STEM professional, has developed a groundbreaking solution: My STEM Resume.
My STEM Resume is a cutting-edge app designed specifically for STEM professionals, offering a comprehensive suite of tools to streamline the resume creation and…  
                                        
                                    
                                                    Animal Stem Cell Therapy Market 2022: Allogeneic Stem Cells Popular Sourcing Cho …                                                
                                            
                                        
                                            The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the years ahead at a CAGR of 5.2% (2022 to 2032).
Request For Free Sample Report of "Animal Stem Cell Therapy Market"@ https://www.persistencemarketresearch.com/samples/14941
Animal stem cell therapies are treatments for disorders such as arthritis, soft tissue injuries, traumatic fractures, tendonitis, inflammatory bowel disease, and others that…  
                                        
                                    
                                                    Animal Stem Cell Therapy Market 2021 Research Report by Experts- Magellan Stem C …                                                
                                            
                                        
                                            Global Animal Stem Cell Therapy Market Size, Status and Forecast 2022
The Global Animal Stem Cell Therapy Market Research Report 2022-2027 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive…  
                                        
                                    
                                                    Stem Cells Market: Development of Infrastructure to Drive Global Stem Cells Mark …                                                
                                            
                                        
                                            In the global stem cells market a sizeable proportion of companies are trying to garner investments from organizations based overseas. This is one of the strategies leveraged by them to grow their market share. Further, they are also forging partnerships with pharmaceutical organizations to up revenues.
Read Report Overview - https://www.transparencymarketresearch.com/stem-cells-market.html
In addition, companies in the global stem cells market are pouring money into expansion through multidisciplinary and multi-sector collaboration for large…  
                                        
                                    
                                                    Global Animal Stem Cell Therapy Market Detailed Analysis 2018-2025 : MediVet Bio …                                                
                                            
                                        
                                            Qyresearchreports include new market research report “Global Animal Stem Cell Therapy Market Research Report 2018” to its huge collection of research reports.
Animal stem cell therapy is a usage of animals stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process…